Nuhad Ibrahim

Nuhad Ibrahim

UNVERIFIED PROFILE

Are you Nuhad Ibrahim?   Register this Author

Register author
Nuhad Ibrahim

Nuhad Ibrahim

Publications by authors named "Nuhad Ibrahim"

Are you Nuhad Ibrahim?   Register this Author

70Publications

1627Reads

11Profile Views

Developing anti-HER2 vaccines: Breast cancer experience.

Int J Cancer 2018 11 10;143(9):2126-2132. Epub 2018 May 10.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.31551
Publisher Site
http://dx.doi.org/10.1002/ijc.31551DOI Listing
November 2018

Development of CNS metastases and survival in patients with inflammatory breast cancer.

Cancer 2018 Jun 26;124(11):2299-2305. Epub 2018 Mar 26.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31336DOI Listing
June 2018

Effect of neoadjuvant chemotherapy regimen on relapse-free survival among patients with breast cancer achieving a pathologic complete response: an early step in the de-escalation of neoadjuvant chemotherapy.

Breast Cancer Res 2018 04 16;20(1):27. Epub 2018 Apr 16.

Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, 1155 Pressler Street CPB5.3540, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-018-0945-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902970PMC
April 2018

Analyses of Pretherapy Peripheral Immunoscore and Response to Vaccine Therapy.

Cancer Immunol Res 2016 09 2;4(9):755-65. Epub 2016 Aug 2.

Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-16-0037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5138028PMC
September 2016

Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases.

J Clin Oncol 2016 Mar 1;34(9):945-52. Epub 2016 Feb 1.

Rachel A. Freedman, Rebecca S. Gelman, Christina Herold, Nicole Ryabin, Sarah Farooq, Elizabeth Lawler, Ian E. Krop, Eric P. Winer, and Nancy U. Lin, Dana-Farber Cancer Institute; Beverly Moy, Massachusetts General Hospital; Alarice Lowe and Nathalie Y.R. Agar, Brigham and Women's Hospital, Boston, MA; Jeffrey S. Wefel, Kenneth R. Hess, and Nuhad Ibrahim, The University of Texas MD Anderson Cancer Center; Polly A. Niravath and Mothaffar F. Rimawi, Baylor College of Medicine, Houston, TX; Michelle E. Melisko, University of California, San Francisco, San Francisco, CA; Roisin M. Connolly and Antonio C. Wolff, Johns Hopkins University, Baltimore, MD; Catherine H. Van Poznak, University of Michigan, Ann Arbor, MI; Shannon L. Puhalla, University of Pittsburgh Cancer Institute and Magee-Women's Hospital, Pittsburgh, PA; Kimberly L. Blackwell, Duke University Medical Center, Durham, NC; and Minetta C. Liu, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2016/01/28/JCO.2015.63
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.63.0343
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.63.0343DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070554PMC
March 2016

Risk stratification in patients with advanced-stage breast cancer by pretreatment [(18) F]FDG PET/CT.

Cancer 2015 Nov 6;121(22):3965-74. Epub 2015 Aug 6.

Division of Diagnostic Imaging, Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29565DOI Listing
November 2015

Phase II Randomized Study of Ixabepilone Versus Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2-Negative Breast Cancer.

Clin Breast Cancer 2015 Oct 24;15(5):325-31. Epub 2015 Mar 24.

Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2015.03.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568133PMC
October 2015

Clinical nomogram to predict bone-only metastasis in patients with early breast carcinoma.

Br J Cancer 2015 Sep 22;113(7):1003-9. Epub 2015 Sep 22.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2015.308DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4651124PMC
September 2015

A phase 1 study with dose expansion of the CDK inhibitor dinaciclib (SCH 727965) in combination with epirubicin in patients with metastatic triple negative breast cancer.

Invest New Drugs 2015 Aug 7;33(4):890-4. Epub 2015 May 7.

Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-015-0244-4DOI Listing
August 2015

Breast cancer with brain metastases: clinicopathologic features, survival, and paired biomarker analysis.

Oncologist 2015 May 23;20(5):466-73. Epub 2015 Mar 23.

Departments of Pathology, Biostatistics, Neurosurgery, and Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0107DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425375PMC
May 2015

CCR 20th Anniversary Commentary: Setting the Stage for Nanoparticle Albumin-Bound Paclitaxel-How Far Science Has Come.

Clin Cancer Res 2015 May;21(9):1975-7

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-2554DOI Listing
May 2015

Survival Advantage in Patients with Metastatic Breast Cancer Receiving Endocrine Therapy plus Sialyl Tn-KLH Vaccine: Post Hoc Analysis of a Large Randomized Trial.

J Cancer 2013 22;4(7):577-84. Epub 2013 Aug 22.

1. Departments of Breast Medical Oncology (NKI, JLM), Melanoma Medical Oncology (DZ), and Surgical Oncology (EAM), The University of Texas MD Anderson Cancer Center, Houston, TX;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/jca.7028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753533PMC
August 2013

Elevated serum P1NP predicts development of bone metastasis and survival in early-stage breast cancer.

Breast Cancer Res Treat 2013 Jan 15;137(2):631-6. Epub 2012 Dec 15.

Department of Breast Medical Oncology, Unit 1354, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-012-2374-0
Publisher Site
http://dx.doi.org/10.1007/s10549-012-2374-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867793PMC
January 2013

Phase I safety and pharmacokinetic study of bavituximab, a chimeric phosphatidylserine-targeting monoclonal antibody, in patients with advanced solid tumors.

Clin Cancer Res 2011 Nov 11;17(21):6888-96. Epub 2011 Oct 11.

Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-1074DOI Listing
November 2011

Dasatinib as a single agent in triple-negative breast cancer: results of an open-label phase 2 study.

Clin Cancer Res 2011 Nov 25;17(21):6905-13. Epub 2011 Oct 25.

Department of Medicine, Division of Hematology, Oncology, Geffen School of Medicine, UCLA Medical Center, Los Angeles, California 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-0288DOI Listing
November 2011

Immunologic mapping of glycomes: implications for cancer diagnosis and therapy.

Front Biosci (Schol Ed) 2011 Jun 1;3:1520-32. Epub 2011 Jun 1.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548420PMC
June 2011

Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers.

J Clin Oncol 2010 Oct 30;28(28):4316-23. Epub 2010 Aug 30.

Department of Breast Medical Oncology, Unit 1354, The University of Texas M. D. Anderson Cancer Center, PO Box 301439, Houston,TX 77230-1439, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.27.2419DOI Listing
October 2010

Ixabepilone development across the breast cancer continuum: a paradigm shift.

Authors:
Nuhad K Ibrahim

Cancer Manag Res 2010 Jun 30;2:169-79. Epub 2010 Jun 30.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004591PMC
June 2010

A phase 2 study of a fixed combination of uracil and ftorafur and leucovorin given orally in a twice-daily regimen to treat patients with recurrent metastatic breast cancer.

Cancer 2010 May;116(10):2301-6

Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25042DOI Listing
May 2010

Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer.

J Clin Oncol 2010 Apr 22;28(12):2032-7. Epub 2010 Mar 22.

FACP, Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Unit 1354, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/28/12/2032.full.pdf
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2009.24.6314
Publisher Site
http://dx.doi.org/10.1200/JCO.2009.24.6314DOI Listing
April 2010

Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer.

Breast Cancer Res 2009 ;11(5):R73

Division of Hematology/Oncology, University of Miami Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, 1475 NW 12th Avenue; Suite 3400 (D8-4), Miami, FL 33136, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr2409DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2790853PMC
March 2010

Therapeutic breast cancer vaccines: a new strategy for early-stage disease.

BioDrugs 2009 ;23(5):277-87

Department of Medicine, San Antonio Military Medical Center, San Antonio, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/11313490-000000000-00000DOI Listing
November 2009

Radiologic findings in taxane induced colitis.

Eur J Radiol 2008 Apr 5;66(1):75-8. Epub 2007 Jun 5.

Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejrad.2007.04.024DOI Listing
April 2008

Albumin-bound Paclitaxel in metastatic breast cancer: viewpoints.

Drugs 2006 ;66(7):949-50

Oncology Research, Broomfield Hospital, Court Road, Chelmsford, Essex, England.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00003495-200666070-00008DOI Listing
September 2006

The impact of immediate breast reconstruction on the technical delivery of postmastectomy radiotherapy.

Int J Radiat Oncol Biol Phys 2006 Sep 9;66(1):76-82. Epub 2006 Jun 9.

Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2006.03.040DOI Listing
September 2006

Nanoparticle albumin-bound paclitaxel for treatment of metastatic breast cancer.

Drugs Today (Barc) 2006 Sep;42(9):599-604

University of Texas M.D. Anderson Cancer Center, Houston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1358/dot.2006.42.9.1009902DOI Listing
September 2006

Aromatase inhibitors in breast cancer: an overview.

Oncologist 2006 Jun;11(6):553-62

Department of Breast Medical Oncology, Unit 424, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.11-6-553DOI Listing
June 2006

Minimal clinical benefit of single agent Orathecin (Rubitecan) in heavily pretreated metastatic breast cancer.

Cancer Chemother Pharmacol 2006 Apr 29;57(4):540-4. Epub 2005 Sep 29.

Department of Breast Medical Oncology, M. D. Anderson Cancer Center, The University of Texas, 1515 Holcombe Boulevard, Unit 424, Houston, TX, 77030-4095, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00280-005-0064
Web Search
http://link.springer.com/10.1007/s00280-005-0064-x
Publisher Site
http://dx.doi.org/10.1007/s00280-005-0064-xDOI Listing
April 2006

Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer.

J Clin Oncol 2005 Sep;23(25):6019-26

Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 424, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2005.11.013
Publisher Site
http://dx.doi.org/10.1200/JCO.2005.11.013DOI Listing
September 2005

Breast cancer molecular subtypes respond differently to preoperative chemotherapy.

Clin Cancer Res 2005 Aug;11(16):5678-85

Department of Breast Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-04-2421DOI Listing
August 2005

Colitis in patients with breast carcinoma treated with taxane-based chemotherapy.

Cancer 2004 Oct;101(7):1508-13

Division of Medical Oncology, Department of Medicine, The University of Texas MD Anderson Cancer Center, Houston 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20546DOI Listing
October 2004

Phase I clinical and pharmacology study of clofarabine in patients with solid and hematologic cancers.

J Clin Oncol 2003 Mar;21(6):1167-73

Departments of Leukemia, Experimental Therapeutics, and Breast and Head and Neck, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2003.04.031DOI Listing
March 2003

Clinical development of the STn-KLH vaccine (Theratope).

Clin Breast Cancer 2003 Feb;3 Suppl 4:S139-43

Department of Breast Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston 77030-4009, USA.

View Article

Download full-text PDF

Source
February 2003

Phase I study of vinorelbine and docetaxel with granulocyte colony-stimulating factor support in the treatment of metastatic breast cancer.

Cancer Invest 2002 ;20(1):29-37

Department of Breast Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030-4009, USA.

View Article

Download full-text PDF

Source
March 2002